Search in:

Advanced search

International Journal of Nanomedicine Volume 5, 2010 - Issue

Submit an article Journal homepage

Open access

107

Views

CrossRef citations to date

Altmetric

Original Research

Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier

Yasutaka Mori1 Research Institute;3 Aeromedical Laboratory, Japan Air Self-Defense Force, Sayama, Saitama, Japan;4 Faculty of System Design, Tokyo Metropolitan University, Hino, Tokyo, Japan

Shingo Nakamura2 Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan

Satoko Kishimoto1 Research Institute

Mitsuyuki Kawakami4 Faculty of System Design, Tokyo Metropolitan University, Hino, Tokyo, Japan

Satoshi Suzuki4 Faculty of System Design, Tokyo Metropolitan University, Hino, Tokyo, Japan

Takemi Matsui4 Faculty of System Design, Tokyo Metropolitan University, Hino, Tokyo, Japan

Masayuki Ishihara1 Research InstituteCorrespondence[email protected]

show all

Pages 147-155 | Published online: 11 Mar 2010

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

DautzenbergHHartmannJGrunewaldSBrandFStoichiometry and structure of polyelectrolyte complex particles in diluted solutionBer Bunsenges Phys Chem1996100610241032
Web of Science ®Google Scholar
WassmerKHSchroederUHornDCharacterization and detection of polyanions by direct polyelectrolyte titrationMakromol Chem19911923553565
Web of Science ®Google Scholar
DraganSCristeaMLucaCSimionescuBCPolyelectrolyte complex. I: Synthesis and characterization of some insoluble polyanion-polycation complexesJ Polym Sci A1996341734873495
Web of Science ®Google Scholar
NordmeierEBeyerPNonstoichiometric polyelectrolyte complexes: A mathematical model and some experimental resultsJ Polym Sci Pol Phys1999374335348
Web of Science ®Google Scholar
ParkJMMuhoberacBBDubinPLXiaJEffect of protein charge heterogeneity in protein-polyelectrolyte complexationMacromolecules1992251290295
Web of Science ®Google Scholar
MattisonKWDubinPLBrittainIJComplex formation between bovine serum albumin and strong polyelectrolytes: Effect of polymer charge densityJ Phys Chem B19981021938303836
Web of Science ®Google Scholar
HolappaSAnderssonTKantonenLPlattnerPTenhuHSoluble polyelectrolyte complexes composed of poly (ethylene oxide)-block-poly (sodium methacrylate) and poly (methacryloyloxyethyl trimethylammonium chloride)Polymer2003442679077916
Web of Science ®Google Scholar
WebsterLHuglinMBRobbIDComplex formation between polyelectrolytes in dilute aqueous solutionPolymer199738613731380
Web of Science ®Google Scholar
HashimotoMKoyamaYSatoTIn vitro gene delivery by pDNA/chitosan complexes coated with anionic PEG derivatives that have a sugar side chainChem Lett2008373266267
Web of Science ®Google Scholar
DenuziereAFerrierDDomardAChitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes. Physico-chemical aspectsCarbohydr Polym1996294317323
Web of Science ®Google Scholar
IshiharaMOnoKStructure and function of heparin and heparan sulfate: heparinoid library and modification of FGF-activitiesTrends Glycosci Glycotechnol19981052223233
Web of Science ®Google Scholar
SalmivirtaMLidholdKLindahlUHeparan sulfate: a piece of informationFASEB J19961011127012798836040
PubMed Web of Science ®Google Scholar
LindahlULidholtKSpillmannDKjellenLMore to “heparin” than anti-coagulationThromb Res19947511328073404
PubMed Web of Science ®Google Scholar
HirshJWarkentinTEShaughnessySGHeparin and low-molecular heparin, mechanisms of action, phormacokinetics, dosing, monitoring, efficacy, and safetyChest20011192 Suppl64S94S11157643
PubMed Web of Science ®Google Scholar
WolztMWetermannANieszpaur-LosMStudies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin®) at the site of activation of the coagulation system in manThromb Haemost19957334394437667826
PubMed Web of Science ®Google Scholar
PanMLezoJSMedinaAIn-laboratory removal of femoral sheath following protamine administration in patients having intra-coronary stent implantationAm J Cardiol19978010133613389388109
PubMed Web of Science ®Google Scholar
FujitaMIshiharaMShimizuMVascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogelBiomaterials200425469970614607508
PubMed Web of Science ®Google Scholar
NakamuraSNambuMKishimotoSEffect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex hydrogel on in vitro and in vivo vascularizationJ Biomed Mater Res A200885361962717806115
PubMed Web of Science ®Google Scholar
NakamuraSKanataniYKishimotoSControlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularizationJ Biomed Mater Res A200991381482319051304
PubMed Web of Science ®Google Scholar
NakamuraSIshiharaMObaraKControlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularizationJ Biomed Mater Res A200678236437116673389
PubMed Web of Science ®Google Scholar
GospodarowiczDChengJHeparin protects basic and acidic FGF from inactivationJ Cell Physiol198612834754843528177
PubMed Web of Science ®Google Scholar
KoetzJKosmellaSPolyelectrolytes and NanoparticlesNew York, NYSpringer2007
Google Scholar
TinkleSSAntoniniJMRichBASkin as a route of exposure and sensitization in chronic beryllium diseaseEnviron Health Perspect200311191202120812842774
PubMed Web of Science ®Google Scholar
VermaDDVermaSBlumeGFahrAParticle size of liposomes influences dermal delivery of substances into skinInt J Pharm20032581214115112753748
PubMed Web of Science ®Google Scholar
MasuokaKIshiharaMAsazumaTThe interaction of chitosan with fibroblast growth factor-2 and its protection from inactivationBiomaterials200526163277328415603823
PubMed Web of Science ®Google Scholar
KishimotoSNakamuraSHattoriHHuman stem cell factor (SCF) is a heparin-binding cytokineJ Biochem2009145327527819074504
PubMed Web of Science ®Google Scholar
OnoKHattoriHTakeshitaSKuritaAIshiharaMStructural features in heparin that interact with VEGF165 and modulate its biological activityGlycobiology19999770571110362840
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date